Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.33
Delayed Data
As of Sep 23
 +0.08 / +0.97%
Today’s Change
5.49
Today|||52-Week Range
9.54
+5.84%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.25
Today’s open8.27
Day’s range8.18 - 8.40
Volume193,896
Average volume (3 months)414,386
Market cap$648.8M
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+120.83%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc-0.13-1.21%
FMIFoundation Medicine ...-0.30-1.23%
PTIProteostasis Therape...+0.22+1.45%
RDNTRadNet Inc0.000.00%
Data as of 09/23/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts

Search for Jobs